Stocks & Investing
Stocks and Investing
Stocks and Investing
Wed, August 31, 2022
[ Wed, Aug 31st 2022
] - WOPRAI
[ Wed, Aug 31st 2022
] - WOPRAI
[ Wed, Aug 31st 2022
] - WOPRAI
[ Wed, Aug 31st 2022
] - WOPRAI
[ Wed, Aug 31st 2022
] - WOPRAI
[ Wed, Aug 31st 2022
] - WOPRAI
[ Wed, Aug 31st 2022
] - WOPRAI
[ Wed, Aug 31st 2022
] - WOPRAI
[ Wed, Aug 31st 2022
] - WOPRAI
[ Wed, Aug 31st 2022
] - WOPRAI
[ Wed, Aug 31st 2022
] - WOPRAI
[ Wed, Aug 31st 2022
] - WOPRAI
[ Wed, Aug 31st 2022
] - WOPRAI
[ Wed, Aug 31st 2022
] - WOPRAI
[ Wed, Aug 31st 2022
] - WOPRAI
[ Wed, Aug 31st 2022
] - WOPRAI
[ Wed, Aug 31st 2022
] - WOPRAI
[ Wed, Aug 31st 2022
] - WOPRAI
[ Wed, Aug 31st 2022
] - WOPRAI
[ Wed, Aug 31st 2022
] - WOPRAI
[ Wed, Aug 31st 2022
] - WOPRAI
[ Wed, Aug 31st 2022
] - WOPRAI
[ Wed, Aug 31st 2022
] - WOPRAI
[ Wed, Aug 31st 2022
] - WOPRAI
[ Wed, Aug 31st 2022
] - WOPRAI
[ Wed, Aug 31st 2022
] - WOPRAI
[ Wed, Aug 31st 2022
] - WOPRAI
Tue, August 30, 2022
[ Tue, Aug 30th 2022
] - WOPRAI
Caroline Palomeque Initiated (ASND) at Strong Buy and Held Target at $166 on, Aug 30th, 2022
Caroline Palomeque of Berenberg, Initiated "Ascendis Pharma A/S" (ASND) at Strong Buy and Held Target at $166 on, Aug 30th, 2022.
Caroline has made no other calls on ASND in the last 4 months.
There are 6 other peers that have a rating on ASND. Out of the 6 peers that are also analyzing ASND, 0 agree with Caroline's Rating of Hold.
These are the ratings of the 6 analyists that currently disagree with Caroline
- Joseph Schwartz of "SVB Leerink" Maintained at Buy with Decreased Target to $168 on, Thursday, August 11th, 2022
- Leland Gershell of "Oppenheimer" Maintained at Buy with Decreased Target to $144 on, Thursday, August 11th, 2022
- Vikram Purohit of "Morgan Stanley" Maintained at Buy with Decreased Target to $148 on, Thursday, August 11th, 2022
- Tiago Fauth of "Credit Suisse" Maintained at Buy with Decreased Target to $123 on, Thursday, May 12th, 2022
- David Lebowitz of "Citigroup" Maintained at Strong Buy with Decreased Target to $158 on, Thursday, May 12th, 2022
- Derek Archila of "Wells Fargo" Maintained at Buy with Decreased Target to $176 on, Thursday, May 12th, 2022
